Brulíková, L.; Chasák, J.; Dak, M.; Šlachtová, V.; Cappoen, D.; Šebela, M.; Berka, K.; Bazgier, V.
New agents for the treatment of drug-resistant Mycobacterium tubercculosis
74. sjezd českých a slovenských chemických společností, September 4 – 7, 2022, Olomouc, přednáška .
Dak, M.; Šlachtová, V.; Šebela, M.; Bazgier, V.; Berka, K.; Smiejkowska, N.; Oorts, L.; Cappoen, D.; Brulíková, L.
Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1
56th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 10 – 12, 2022, Špindlerův mlýn, poster .
Šlachtová, V.; Dak, M.; Šebela, M.; Cappoen, D.; Berka, K; Bazgier, V.; Brulíková, L.
Synthesis of novel potential mycobacterial Zmp1 inhibitors
56th International Conference on Medicinal Chemistry, July 7 – 9, 2021, virtual event, poster .
Šlachtová, V.; Brulíková, L.
Novel Approaches for the Synthesis of 2-Aminobenzoxazoles and their N-Substituted Derivatives
XIX. Interdisciplinary Meeting of Young Life Scientists, 20.-23.05., 2019, Milovy, přednáška .
Šlachtová, V.; Brulíková, L.
Novel Approaches to 2-Aminobenzoxazoles
21st European Symposium on Organic Chemistry, 14.-18.07., 2019, Vienna, poster .
Brulíková, L.; Šlachtová, V.; Šebela, M.; Cappoen, D.
Synthesis of novel mycobacterial Zmp1 inhibitors
18th Blue Danube Symposium on Heterocyclic Chemistry, september 18 – 21, 2019, Ljublan, Slovinsko, přednáška .
Šlachtová, V.; Janovská, L.; Brulíková, L..
Solid phase synthesis of new thiazolidinediones and their antimicrobial activity
70. sjezd českých a slovenských chemických společností, September 9-12, 2018, Zlín (Czech Republic), poster .